Related Experiment Videos
HLA polymorphisms and T cells in rheumatoid arthritis
1Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA. weyand.cornelia@mayo.edu
International Reviews of Immunology
|December 30, 1999
Summary
Rheumatoid arthritis (RA) involves T cells attacking the body, potentially stemming from a systemic autoimmune disease rather than a localized joint issue. This suggests widely distributed antigens drive the chronic immune response in RA.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Rheumatoid arthritis (RA) is characterized by immune cell infiltration in the synovial membrane, forming structures resembling secondary lymphoid tissues.
- T cells are implicated in RA pathogenesis, with HLA genes being a significant risk factor, particularly HLA-DRB1.
- The diverse T cell receptor repertoire in RA infiltrates, including clonally expanded populations, suggests a complex immune response.
Purpose of the Study:
- To investigate the role of T cells and HLA genes in rheumatoid arthritis pathogenesis.
- To explore the systemic nature of rheumatoid synovitis and identify potential antigens driving the immune response.
Main Methods:
- Analysis of T cell infiltrates in synovial membranes.
- Investigation of HLA gene associations with RA risk, progression, and severity.
- Studies using T cell receptor transgenic animal models.
Main Results:
- Clonally expanded CD4 T cell populations with deficient CD28 expression and autoreactivity were identified in RA patients.
- These autoreactive T cells are not confined to the joint, suggesting a systemic autoimmune process.
- T cell responses to ubiquitously expressed self-MHC molecules in animal models induce synovial inflammation.
Conclusions:
- Rheumatoid synovitis may be a manifestation of a systemic autoimmune disease, not solely a joint-specific condition.
- Widely distributed antigens, rather than joint-specific ones, likely drive the chronic immune response in RA.
- Understanding the systemic nature of RA is crucial for identifying pathogenic antigens and developing effective treatments.